The
biopharmaceutical industry is continuously undergoing organizational changes
intended to better support the healthcare industries while maintaining quality
and reducing cost. A new article by Allan Marinelli, for Pharmaceutical Online,
illustrates how manufacturers can add value to their operations by using a
quality validation risk management approach for the development of sampling
plans. Establishing a quality validation risk management approach for all
pharmaceutical processes would increase the probability of successful outcomes
for both the companies producing the products — by helping to meet regulatory
requirements — while better contributing to the quality of healthcare for
patients.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources